SBShams E. Tabriz Bhuiyan

Shams E. Tabriz Bhuiyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shams E. Tabriz Bhuiyan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Adiba Tasnim

    Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh

    1 shared publication
  • Aleza Sharmin Ema

    Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh

    1 shared publication
  • Ayesha Afrin

    Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh

    1 shared publication
  • Debashis Sen

    Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh

    1 shared publication
  • Fahmida Chowdhury

    Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh

    1 shared publication
  • Fahmida Dil Farzana

    Office of Executive Director (OED), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh

    1 shared publication

Latest Publications

  • Open Access

    High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance

    by Tanzir Ahmed Shuvo, Sifat Binte Ibrahim, Nusrat Jahan Shaly, Md. Shoieb Ul Haque, Fahmida Dil Farzana, Farhat Jaby, Md. Kamrul Islam, Adiba Tasnim, Shams E. Tabriz Bhuiyan, Nuzhat Shamiha Alam, et al.

    Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.